← Back to Search

Other

PPE and Training for Silicosis

N/A

Recruiting

Led By William Checkley, MD, PhD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Cognitively capable to provide informed consent

Age 18 years or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial aims to reduce risk of silicosis in Nepali brick kiln workers by providing personal protective equipment (PPE) and training.

Who is the study for?

This trial is for adult brick kiln workers in Bhaktapur, Nepal who are at risk of silicosis due to silica exposure. Participants must be over 18 years old and able to give informed consent. It excludes those not working in brick kilns, under 18, or unable to consent.Check my eligibility

What is being tested?

The study tests a training program on using personal protective equipment (PPE) like N95 respirators and protective eyewear to reduce silica inhalation among workers. The intervention includes a workshop designed with the Discover, Design, Build, Test framework.See study design

What are the potential side effects?

There may be no direct medical side effects from participating as this trial focuses on educational interventions and PPE use. However, discomfort or difficulty wearing PPE such as respirators could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am mentally able to understand and agree to the study's procedures.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility as assessed by The Feasibility of Intervention Measure (FIM) score

Trial Design

4Treatment groups

Experimental Treatment

Group I: Pilot Study: Personal Protective Equipment Training ProgramExperimental Treatment2 Interventions

A small training program will be offered to brick kiln workers to determine preferred PPE type, feasibility in the work environment and proper usage of PPE.

Group II: Feedback Workshop on Pilot Personal Protective Equipment Training ProgramExperimental Treatment1 Intervention

Group III: Design of Personal Protective Equipment Training WorkshopExperimental Treatment1 Intervention

Group IV: Baseline Survey: Silicosis and Personal Protective EquipmentExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

N95 Respirator

2019

N/A

~2950

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Chiesi FoundationUNKNOWN

2 Previous Clinical Trials

316 Total Patients Enrolled

Fogarty International Center of the National Institute of HealthNIH

128 Previous Clinical Trials

162,903 Total Patients Enrolled

Johns Hopkins UniversityLead Sponsor

2,273 Previous Clinical Trials

14,840,192 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open opportunities to join this medical research?

"Information on clinicaltrials.gov suggests that this medical study is not actively recruiting participants at present; the trial was initially posted on December 1st 2023, with a last update occurring October 13th 2023. However, there are 4 other trials searching for patients presently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Reducing Silica Exposure Among Brick Kiln Workers in Nepal

2024. "Reducing Silica Exposure Among Brick Kiln Workers in Nepal". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06090370.